Feasibility of a Home Hazard Management Program for Malaysian Stroke Survivors
NCT ID: NCT04618029
Last Updated: 2022-05-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2021-01-01
2022-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low-Volume Interval Training and Resistance Exercise in Individual With Stroke
NCT04623060
The Effect of Home-Based Telerehabilitation in Individuals With Stroke
NCT05083195
Effect of Aerobic Exercise Training on Balance, Walking Capacity, and Quality of Life in Sub-acute Stroke.
NCT04377022
Effects Of Task-Oriented Training In Individuals With Stroke
NCT05671211
Understanding Different Parameters in Locomotor Training (a Type of Walking Training) for Person After a Stroke
NCT00712179
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Convenient sampling will be conducted as the sampling method for this study. Any participants that fulfil the inclusion criteria will be approach for participation. Information of potential participants will be retrieved from the appointment book or online appointment system as well as their medical records. The screening and recruitment of participants will occur on the same day as their appointment at the hospital by a co-investigator at site. Prior to participating, all participants are required to fill up a written consent form. The co-investigator at site will approach the participants and explain in detail about the study. Information regarding the study, the risk and benefits, confidentiality, withdrawal from the study and questionnaires will also be conveyed. Participants will also be informed that they will not be paid for their participation, but they will receive a certificate of appreciation. Potential participants will be allowed sufficient time to consider their participation in the study. Consented participants will be screened using the Modified Rankin Scale and the 6-item Cognitive Impairment Test and be invited to take part in the study. The participants will be conveniently located into two different groups, namely the intervention group and the control group. All participants will be given an appointment for an online telehealth session according to the participants appropriate time. The telehealth platform that will be used for this study is Coviu-an integrated and specialized telehealth platform which is HIPAA-compliant (https://www.coviu.com/). A falls diary will also be given to participants by email or mail to record any falls they encountered within 3 months after the initial assessment. The participants will then be re-assessed after the 3 months from the initial baseline assessments. During the 3 months follow up, the participants are re-assessed using the same initial baseline questionnaires. The falls dairy will also be collected via email for analysis.
Recruitment of participants during the initial baseline assessment will stop once it has reached 30 participants. However, withdrawal participants will be replaced, until the required sample size is achieved. Hospital Selayang and Hospital Pengajar UPM is conveniently chosen as the hospital for the intervention group while Hospital Shah Alam is chosen for the control group. These hospitals are chosen because of its accessibility for the researchers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
* Two independent assessor will be recruited for data collection and data analysis of outcomes
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment Group
1. Home Assessment and Modification A two-component individualized home hazards management program will be provided for each participant in the intervention group according to the results of the HOME FAST. Basic home safety strategies and basic modifications are developed and will be prescribed for this study according to the HOME FAST assessment (weeks et al. 2010)
2. Education Education on optimization of functional performance in the home will be provided via pamphlets on fall prevention, including energy conservation techniques (Chumbler et al., 2010), ergonomics (Edwards et al., 2019) and task simplification techniques (Wesson et al., 2013) will be provided. These techniques will also be provided for participants' caregivers.
Home Modification
Home Modification Intervention
Floor
Provide recommendations to:
* Fix the back of the rugs and mats with adhesive/heavy duty tape
* Buy non-slip mats
* Tie all cables with a proper cable tie
Lighting
Provide recommendations to:
* Buy a torch light
* To replace worn light bulbs
* Buy a light switch
Bathroom
Provide recommendations to:
* Buy a non-slip mat
* Install a grab rail
* Buy a commode chair for showering
Stairways
Provide recommendations to:
• Fix an adhesive tape for stair contrast
Education
Techniques Description Energy Conservation
* Take your time
* Go to the toilet more often, so you don't have to rush
* Use a nearby toilet: commode, different bathroom
* Prepare ahead (e.g., toilet paper near, other items for toileting, etc.)
* Adjust equipment before changing position
* Avoid transfers when tired
* Ask for help if you feel sick or especially tired
* Allow time for eyes to adjust to change in lighting
Task Simplification
* Plan and organise workspaces to eliminate unnecessary steps, save time, energy and reduce fatigue.
* Prioritise and plan activities, alternating between active and quiet jobs and include rest periods.
Ergonomics
* Proper positioning while doing tasks
* Safe mobility around the home
Controlled Group
1\. Standard Care The standard care defined for this study is any care that are provided from the respective hospital. This will include common therapies and interventions for stroke rehabilitation in general.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home Modification
Home Modification Intervention
Floor
Provide recommendations to:
* Fix the back of the rugs and mats with adhesive/heavy duty tape
* Buy non-slip mats
* Tie all cables with a proper cable tie
Lighting
Provide recommendations to:
* Buy a torch light
* To replace worn light bulbs
* Buy a light switch
Bathroom
Provide recommendations to:
* Buy a non-slip mat
* Install a grab rail
* Buy a commode chair for showering
Stairways
Provide recommendations to:
• Fix an adhesive tape for stair contrast
Education
Techniques Description Energy Conservation
* Take your time
* Go to the toilet more often, so you don't have to rush
* Use a nearby toilet: commode, different bathroom
* Prepare ahead (e.g., toilet paper near, other items for toileting, etc.)
* Adjust equipment before changing position
* Avoid transfers when tired
* Ask for help if you feel sick or especially tired
* Allow time for eyes to adjust to change in lighting
Task Simplification
* Plan and organise workspaces to eliminate unnecessary steps, save time, energy and reduce fatigue.
* Prioritise and plan activities, alternating between active and quiet jobs and include rest periods.
Ergonomics
* Proper positioning while doing tasks
* Safe mobility around the home
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being diagnosed with first-time or recurrent stroke within 24 months (American Heart Association, 2013)
* Has been discharged from in-patient wards and is living in the community
* Undergoing outpatient rehabilitation
* Slight disability to moderately severe disability according to the Modified Rankin Scale
* Able to walk for a minimum of 10 metres unsupported (with or without aid)
* Cognitively intact (score \<8 on the 6-item Cognitive Impairment Test) and
* Able to speak and understand Malay or English. The researcher will again verify the criteria of the included participants.
Participants will be excluded if they have at least one of the following criteria:
* Bed-bound
* Clinically diagnosed dementia according to ICD-11 definition
* Major psychiatric illnesses or psychosis (i.e. schizophrenia, paranoia)
* Diagnosed with aphasia
* Medically unstable for example unstable angina or untreated fits,
* Pregnant and
* Participants who had a prior home assessment and modification will also be excluded.
Withdrawal Criteria:
* Patients who withdraw at any time of the study
* Patients who have a recurrent stroke during the time of study with a new Modified Rankin Scale of 5 or 6
45 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universiti Putra Malaysia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Husna Ahmad Ainuddin
Principal Investigator and Doctoral Student, Department of Rehabilitation, Faculty of Medicine and Health Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Muhammad Hibatullah Romli, PhD
Role: PRINCIPAL_INVESTIGATOR
UPM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Selayang
Selayang Baru Utara, , Malaysia
Hospital UPM
Serdang, , Malaysia
Hospital Shah Alam
Shah Alam, , Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NMRR-20-501-52933
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.